Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Other Accumulated Expenses (2011 - 2026)

Verastem (VSTM) posted quarterly Other Accumulated Expenses of $857000.0 for Q1 2026, down 49.79% year-over-year from $1.7 million in Q1 2025, and down 71.58% quarter-over-quarter from $3.0 million in Q4 2025.

Analysis

Verastem (VSTM) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

Verastem's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $857000.0 for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses fell 49.79% year-over-year to $857000.0; the TTM figure through Mar 2026 stood at $857000.0 (down 49.79% YoY), while the FY2025 annual figure was $3.0 million, up 805.41% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $857000.0, down from $3.0 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $12.6 million in Q2 2022, with the low at $183000.0 in Q2 2025.
  • The 5-year median for Other Accumulated Expenses is $1.2 million (2024), against an average of $3.2 million.
  • The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses plunged 92.31% in 2024, then soared 805.41% in 2025.
  • Verastem's Other Accumulated Expenses stood at $996000.0 in 2022, then climbed by 8.13% to $1.1 million in 2023, then plunged by 69.08% to $333000.0 in 2024, then jumped by 805.41% to $3.0 million in 2025, then plunged by 71.58% to $857000.0 in 2026.
  • Business Quant data shows VSTM's Other Accumulated Expenses at $857000.0 in Q1 2026, $3.0 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.90 Mn
Mar 31, 2026 3.14 Mn
Dec 31, 2025 3.02 Mn
Sep 30, 2025 2.02 Mn
Jun 30, 2025 1.78 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 1.36 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 1.18 Mn
Mar 31, 2024 1.28 Mn
Dec 31, 2023 1.08 Mn
Sep 30, 2023 9.05 Mn
Jun 30, 2023 7.70 Mn
Mar 31, 2023 8.95 Mn
Dec 31, 2022 996,000.00
Sep 30, 2022 8.16 Mn
Jun 30, 2022 12.62 Mn
Mar 31, 2022 9.37 Mn
Dec 31, 2021 9.31 Mn
Sep 30, 2021 7.38 Mn